{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor\u2013Associated Myocarditis | JACC: CardioOncology","description":"Research fellow, Adrian Chen, discusses a multicenter study evaluating myocardial PD\u2011L1 expression as a prognostic biomarker in immune checkpoint inhibitor\u2013associated myocarditis. The conversation highlights how elevated myocardial PD\u2011L1 identifies patients at markedly higher risk for early adverse cardiac events and explores its potential role in improving risk stratification and guiding earlier, more aggressive therapy in this high\u2011risk population. ","author_name":"JACC Specialty Journals","author_url":"https:\/\/www.jacc.org","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40955810\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/40955810"}